BRNS logo

BRNS
Barinthus Biotherapeutics PLC - ADR

160
Mkt Cap
$27.91M
Volume
1,780.00
52W High
$2.92
52W Low
$0.512
PE Ratio
-0.53
BRNS Fundamentals
Price
$0.6825
Prev Close
$0.6832
Open
$0.6627
50D MA
$0.6229
Beta
0.72
Avg. Volume
19,083.87
EPS (Annual)
-$1.64
P/B
0.42
Rev/Employee
$0.00
$32.11
Loading...
Loading...

About

Barinthus Biotherapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development of antigen-specific immunotherapeutics that induce T cells to treat chronic viral infections, autoimmune diseases, and cancer. It also focuses on the pipeline of both clinical and preclinical stage therapeutic, and prophylactic programs. The company was founded by Adrian Hill and Dame Sarah Gilbert in March 2021 and is headquartered in Didcot, the United Kingdom.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
14

Frequently Asked Questions

What is Market Cap of Barinthus Biotherapeutics Plc. - ADR?
What is the 52-week high for Barinthus Biotherapeutics Plc. - ADR?
What is the 52-week low for Barinthus Biotherapeutics Plc. - ADR?
What is Barinthus Biotherapeutics Plc. - ADR stock price today?
What was Barinthus Biotherapeutics Plc. - ADR stock price yesterday?
What is the PE ratio of Barinthus Biotherapeutics Plc. - ADR?
What is the Price-to-Book ratio of Barinthus Biotherapeutics Plc. - ADR?
What is the 50-day moving average of Barinthus Biotherapeutics Plc. - ADR?
How many employees does Barinthus Biotherapeutics Plc. - ADR have?

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available